In patients with high-grade serous carcinoma, a high-level FABP4 in primary ovarian cancer tissue was found to be significantly associated with increased incidence of residual disease after primary debulking surgery, indicating the possibility that FABP4 expression is an important decision factor for beneficial surgical interventions [50]. The gene discussed is FABP4; the disease is ovarian carcinoma.